Hall Private Wealth Advisors’s AbbVie ABBV Stock Holding History

Hall Private Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-51,190	Closed	-$8.16M	–	47
2023 Q1	$8.16M	Sell	51,190 -11,821	-19%	-$1.81M	4.25%	7
2022 Q4	$10.2M	Sell	63,011 -3,338	-5%	-$512K	5.79%	6
2022 Q3	$8.9M	Buy	66,349 +4,798	+8%	+$689K	5.13%	8
2022 Q2	$9.43M	Sell	61,551 -12,000	-16%	-$1.83M	5.29%	8
2022 Q1	$11.9M	Buy	73,551 +375	+0.5%	+$54.5K	6.37%	5
2021 Q4	$9.91M	Buy	73,176 +6,243	+9%	+$737K	6.16%	5
2021 Q3	$7.22M	Buy	66,933 +52,203	+354%	+$5.96M	4.6%	10
2021 Q2	$1.66M	Buy	+14,730	New	+$1.66M	1.08%	24

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hall Private Wealth Advisors's ABBV Position: Q2 2023 in Review

Hall Private Wealth Advisors sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 51,190 shares — an estimated $8.16M sold.

Hall Private Wealth Advisors first reported a position in ABBV in Q2 2021 and held it in 8 quarters. The position peaked at $11.9M in Q1 2022. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

Hall Private Wealth Advisors reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
Hall Private Wealth Advisors sold 51,190 AbbVie shares in Q2 2023, an estimated $8.16M.
Hall Private Wealth Advisors first reported a position in AbbVie in Q2 2021 and held it in 8 quarters.
Hall Private Wealth Advisors's AbbVie position peaked at $11.9M in Q1 2022.
3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Hall Private Wealth Advisors's 13F filing for Q2 2023, filed 17 Jul 2023.